A prominent CAF-S1 subset corresponds to the reduction of CD8+ T-cell content and the high number of FOXP3+ T cells in the TNBC tumor bed, which play an immunosuppressive role and are a potential intervention target (A. Costa et al., 2018). This evidence concerns the gene CD8A and neoplasm.